matthijs smith

Momentum building for Medtech microcap Dorsavi

Canaccord Genuity
Canaccord Genuity
Stockbroker

Getting pumped about AirXpanders

Canaccord Genuity
Canaccord Genuity
Stockbroker

Impedimed: Getting Significant Recognition In The Medical Community

Canaccord Genuity
Canaccord Genuity
Stockbroker

Ground-breaking study may lead to accelerated sales pipeline for Nanosonics

Canaccord Genuity
Canaccord Genuity
Stockbroker

QRXPharma just saw its market cap shrink 75% from $120mil to $30mil on the FDA saying 'no', as Matthijs smith warned Livewire yesterday: There is unlikely to...

Livewire Equities
Livewire Equities
Livewire